Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.

The trial of percutaneous left atrial appendage closure vs direct oral anticoagulants in patients with AF is called positive, ...

A subgroup analysis of the VASALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.

The landscape of topical therapies for melasma is evolving quickly as a steady stream of new agents becomes available, offering alternatives to traditional frontline strategies, a dermatologist told ...

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

A population-based, prospective cohort study conducted in China finds that lung cancer risk remains low until 3 years after a negative low-dose CT screen.

In patients with GERD, dominant symptom intensity is a simple patient-reported measure that identifies the most burdensome ...

Elinzanetant reduces the severity and frequency of hot flushes and night sweats among women with breast cancer regardless of ...

A chest-worn biosensor that features several measurement signals in one device reliably identifies the presence and severity ...

Vall d’Hebron reorganized care into Knowledge Areas; the Heart Area pilot cut length of stay by 18%, 30-day readmissions by ...

New data confirm similar response rates with fewer toxicities when carboplatin is dropped from standard neoadjuvant therapy in early HER2-positive breast cancer.

An investigative inhaled formulation of the psychedelic mebufotenin is linked to significant improvements in depression ...